Jian‐xing Ma
- Ophthalmology top 0.05%
- Retinal Diseases and Treatments 116
- Glaucoma and retinal disorders 24
- Molecular Biology top 0.5%
- Retinal Development and Disorders 74
- Retinoids in leukemia and cellular processes 28
- Angiogenesis and VEGF in Cancer 26
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research 25
-
- Corneal Surgery and Treatments 26
- Biochemistry top 1%
-
- Photoreceptor and optogenetics research 21
Jian‐xing Ma
286 papers receiving 11.9k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Ophthalmology 4.3k
- Molecular Biology 7.5k
- Clinical Biochemistry 687
- Radiology, Nuclear Medicine and Imaging 2.0k
- Biochemistry 449
Countries citing papers authored by Jian‐xing Ma
This map shows the geographic impact of Jian‐xing Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian‐xing Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian‐xing Ma more than expected).
Fields of papers citing papers by Jian‐xing Ma
This network shows the impact of papers produced by Jian‐xing Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian‐xing Ma. The network helps show where Jian‐xing Ma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jian‐xing Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 15 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 2 | |
| 9 | 2021 | 14 | |
| 10 | 2018 | 16 | |
| 11 | 2018 | 8 | |
| 12 | THE PATHOGENIC ROLE OF DOWN-REGULATION OF PPAR-ΑLPHA EXPRESSION IN DIABETIC RETINOPATHY | 2013 | 1 |
| 13 | 2011 | 20 | |
| 14 | 2011 | 55 | |
| 15 | Increased Serum Kallistatin Levels in Patients With Type 1 Diabetes and Its Vascular Complications | 2010 | 1 |
| 16 | 2009 | 133 | |
| 17 | Kallikrein-Binding Protein Protects Retinal Müller Cells Against H2O2-Induced Cell Death by Inhibiting Calcium Overload | 2007 | 1 |
| 18 | 2005 | 54 | |
| 19 | Iron Is Required for the Isomerohydrolase Activity in the Visual Cycle | 2005 | 1 |
| 20 | 2000 | 5 |
About Jian‐xing Ma
Jian‐xing Ma is a scholar working on Ophthalmology, Clinical Biochemistry and Molecular Biology, having authored 296 papers that have together received 12.1k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (116 papers), Retinal Development and Disorders (74 papers), Retinoids in leukemia and cellular processes (28 papers), Angiogenesis and VEGF in Cancer (26 papers), Corneal Surgery and Treatments (26 papers), Advanced Glycation End Products research (25 papers), Glaucoma and retinal disorders (24 papers) and Photoreceptor and optogenetics research (21 papers). The work is most often cited by research in Ophthalmology (4.3k citations), Molecular Biology (7.5k citations) and Clinical Biochemistry (687 citations). Jian‐xing Ma has collaborated with scholars based in United States, China and France. Frequent co-authors include Gennadiy Moiseyev, Yusuke Takahashi, Sarah X. Zhang, Rosalie K. Crouch, Rui Cheng, Guoquan Gao, Yang Hu, Kelu Zhou, Ying Chen and Joshua J. Wang. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Diabetes, Journal of Biological Chemistry, Experimental Eye Research and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.